chevron_leftBack
As of 6 June 2026, Futura Medical plc has a market cap of $10.15M USD, ranking #41213 globally and #935 in the United Kingdom.
It ranks #3664 in the Healthcare sector, and #248 in the Drug Manufacturers - Specialty & Generic industry.
Key Stats
Market Cap
$10.15MUSD
7.56M GBP
Enterprise Value
$5.16MUSD
3.87M GBP
Revenue (TTM)
$10.64MUSD
7.93M GBP
EBITDA (TTM)
-$8.24MUSD
-6.18M GBP
Net Income (TTM)
-$8.45MUSD
-6.29M GBP
EBITDA Margin
-78%
Profit Margin
-79%
PS Ratio
1.0
PB Ratio
2.5
Company Profile
Country (HQ)
Sector
Healthcare
CEO
Alexander James Duggan
open_in_new
Employees
14
Founded
2001
Website
futuramedical.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -32% | -3.7% | 16% | -3% | -52% | -86% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
FUM
Futura Medical PLC
ISIN: GB0033278473
Shares Out.:
Shares Outstanding:
581.328M1
Shares Float:
493.896M2
|
0.8900 GBX | |
|
FAMDF
Futura Medical PLC
ISIN: GB0033278473
Shares Out.:
Shares Outstanding:
303.704M1
Shares Float:
248.907M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.1220 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical gel for the treatment of erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
LSE: HIK
|
$4.01B
39K%
2.98B GBP
|
10.3
|
|
LSE: AGY
|
$875.65M
9K%
652.25M GBP
|
-
|
|
LSE: APN
|
$721.59M
7K%
537.5M GBP
|
19.5
|
|
LSE: ANCR
|
$308.67M
3K%
229.92M GBP
|
73.8
|
|
LSE: IMM
|
$35.18M
247%
26.2M GBP
|
-
|
|
LSE: PXS
|
$32.28M
218%
24.05M GBP
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TLV: TEVA
|
$37.66B
371K%
108.92B ILS
|
24.2
|
|
NASDAQ: RVMD
|
$29.56B
291K%
|
-
|
|
SHE: 002001
|
$15.86B
156K%
107.34B CNY
|
16.0
|
|
NSE: CIPLA
|
$11.12B
109K%
1.06T INR
|
23.4
|
|
NSE: LUPIN
|
$11.0B
108K%
1.05T INR
|
22.7
|
|
SHE: 002653
|
$9.1B
90K%
61.6B CNY
|
80.6
|
chevron_leftBack